These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9676824)

  • 1. Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity.
    Gurguis GN; Yonkers KA; Blakeley JE; Phan SP; Williams A; Rush AJ
    Psychiatry Res; 1998 Jun; 79(1):31-42. PubMed ID: 9676824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity.
    Gurguis GN; Yonkers KA; Phan SP; Blakeley JE; Williams A; Rush AJ
    Biol Psychiatry; 1998 Oct; 44(7):600-9. PubMed ID: 9787884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).
    Reed SC; Levin FR; Evans SM
    Horm Behav; 2008 Jun; 54(1):185-93. PubMed ID: 18413151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Generalized Anxiety Disorder and Premenstrual Dysphoric Disorder in a Diagnostic Interviewing Study.
    Yen JY; Lin PC; Huang MF; Chou WP; Long CY; Ko CH
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32033286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressive mood and frontal alpha asymmetry during the luteal phase in premenstrual dysphoric disorder.
    Lin IM; Tsai YC; Peper E; Yen CF
    J Obstet Gynaecol Res; 2013 May; 39(5):998-1006. PubMed ID: 23551544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menstrual cycle effects on amygdala reactivity to emotional stimulation in premenstrual dysphoric disorder.
    Gingnell M; Morell A; Bannbers E; Wikström J; Sundström Poromaa I
    Horm Behav; 2012 Sep; 62(4):400-6. PubMed ID: 22814368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes.
    Halbreich U; Piletz JE; Carson S; Halaris A; Rojansky N
    Biol Psychiatry; 1993 Nov; 34(10):676-86. PubMed ID: 7904832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle.
    Kask K; Gulinello M; Bäckström T; Geyer MA; Sundström-Poromaa I
    Neuropsychopharmacology; 2008 Aug; 33(9):2283-90. PubMed ID: 17940552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature circadian rhythms during the menstrual cycle and sleep deprivation in premenstrual dysphoric disorder and normal comparison subjects.
    Parry BL; LeVeau B; Mostofi N; Naham HC; Loving R; Clopton P; Gillin JC
    J Biol Rhythms; 1997 Feb; 12(1):34-46. PubMed ID: 9104689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder.
    Epperson CN; Pittman B; Czarkowski KA; Stiklus S; Krystal JH; Grillon C
    Neuropsychopharmacology; 2007 Oct; 32(10):2190-8. PubMed ID: 17314917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.
    Girdler SS; Straneva PA; Light KC; Pedersen CA; Morrow AL
    Biol Psychiatry; 2001 May; 49(9):788-97. PubMed ID: 11331087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
    Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
    Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests.
    Inoue Y; Terao T; Iwata N; Okamoto K; Kojima H; Okamoto T; Yoshimura R; Nakamura J
    Psychopharmacology (Berl); 2007 Feb; 190(2):213-9. PubMed ID: 17072588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain activation during emotion regulation in women with premenstrual dysphoric disorder.
    Petersen N; Ghahremani DG; Rapkin AJ; Berman SM; Liang L; London ED
    Psychol Med; 2018 Aug; 48(11):1795-1802. PubMed ID: 29145910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced phase-advance of plasma melatonin after bright morning light in the luteal, but not follicular, menstrual cycle phase in premenstrual dysphoric disorder: an extended study.
    Parry BL; Meliska CJ; Sorenson DL; Martínez LF; López AM; Elliott JA; Hauger RL
    Chronobiol Int; 2011 May; 28(5):415-24. PubMed ID: 21721857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases.
    Le Mellédo JM; Merani S; Koszycki D; Bellavance F; Palmour R; Gutkowska J; Steinberg S; Bichet DG; Bradwejn J
    Neuropsychopharmacology; 1999 Jan; 20(1):81-91. PubMed ID: 9885787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep EEG studies during early and late partial sleep deprivation in premenstrual dysphoric disorder and normal control subjects.
    Parry BL; Mostofi N; LeVeau B; Nahum HC; Golshan S; Laughlin GA; Gillin JC
    Psychiatry Res; 1999 Feb; 85(2):127-43. PubMed ID: 10220004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls.
    Girdler SS; Sherwood A; Hinderliter AL; Leserman J; Costello NL; Straneva PA; Pedersen CA; Light KC
    Psychosom Med; 2003; 65(5):849-56. PubMed ID: 14508031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder.
    Batra NA; Seres-Mailo J; Hanstock C; Seres P; Khudabux J; Bellavance F; Baker G; Allen P; Tibbo P; Hui E; Le Melledo JM
    Biol Psychiatry; 2008 Jun; 63(12):1178-84. PubMed ID: 18061146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Working memory deficit in premenstrual dysphoric disorder and its associations with difficulty in concentrating and irritability.
    Yen JY; Chang SJ; Long CY; Tang TC; Chen CC; Yen CF
    Compr Psychiatry; 2012 Jul; 53(5):540-5. PubMed ID: 21821238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.